Syncope - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Syncope

Description:

Syncope Teresa Menendez Hood , M.D. Definition Syncope is a symptom in which there is transient ( – PowerPoint PPT presentation

Number of Views:194
Avg rating:3.0/5.0
Slides: 36
Provided by: Teresa199
Learn more at: http://phdres.caregate.net
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Syncope


1
Syncope
  • Teresa Menendez Hood , M.D.

2
Definition
  • Syncope is a symptom in which there is transient
    (lt30 secs) and self-limited loss of consciousness
    usually leading a fall. The onset is rapid and
    recovery is spontaneous, complete and prompt. The
    underlying mechanism is relatively abrupt
    cerebral hypoperfusion.The onset may or may not
    have warning and some older patients may have
    retrograde amnesia. Fatigue is common
    post-syncope.
  • Just this week Palestinian leader improving
    after collapse

3
SYNCOPE STATS
  • 25 people will have syncope at some point
  • 6 of hospital admits are for syncope
  • 3 of all ER visits
  • 30 have recurrences
  • 40 remain undiagnosed after initial evaluation

4
Syncope Etiology
Orthostatic
Cardiac Arrhythmia
Structural Cardio- Pulmonary
Non- Cardio- vascular
Neurally- Mediated


24
14
12
11
4
Unknown Cause 34
DG Benditt, UM Cardiac Arrhythmia Center
5
Causes of Syncope
  • Neurally-mediated reflex syncope-a reflex that
    when triggered gives rise to vasodilation and/or
    bradycardia
  • Vasovagal-look for precipitating events fear,
    pain, prolonged standing
  • Carotid sinus-turning head to one side, age gt40
  • Situational-cough, micturition, post-exercise,
    post-prandial, swallow, defecation.

6
Causes of Syncope
  • Orthostatic
  • Autonomic Failure- the autonomic nervous system
    does not work well and one does not get the
    vasoconstrictor mechanisms to upright posture
  • primary or multisystem, secondary (DM, amyloid),
    drug induced (the most common). Look for
    autonomic problems in other organs..i.e cannot
    sweat, impotence, disturbed micturition
  • Volume depletion
  • Cardiac Arrhythmias
  • Sinus node dysfunction, AVN disease, SVT/VT,
    inherited diseases(LQT, Brugada, WPW,ARVD,HCM)

7
Causes of Syncope
  • Structural Cardiac or Cardiopulmonary disease-an
    obstruction of blood flow
  • Valvular disease
  • Obstructive CM
  • Atrial Myxoma
  • Aortic dissection
  • Tamponade
  • PE

8
Causes of Syncope
  • Cerebrovascular
  • Vascular steal syndrome-subclavian stealrare,
    syncope associated with arm exercise the blood
    vessel supplies both the brain and the arm. Check
    for BP in both arms!
  • Vetebrobasilar TIA-doubtful that can really cause
    syncope

9
Features suggestive of cardiac causes?
  • Occur in the supine position or during exertion
  • Preceded by palpitations
  • Presence of severe heart disease
  • EKG abnormalities wide QRS, AV conduction
    disease, Q waves, LQT, delta wave

10
Features suggestive of Neurally-Mediated causes?
  • Prolonged standing in crowded, warm place
  • Preceding nausea, feeling cold and sweaty
  • After exertion or post-prandial
  • Tonic-clonic movements are short in duration and
    occur after the loss of consciousness
  • Long duration of symptoms gt4years

11
Causes of non-syncopal attacks
  • Impairment of /loss of consciousness
  • Metabolic-hypoglycemia , hypoxia,
    hyperventilation syndrome
  • Epilepsy-Typical premonitory aura? Post-ictal
    state?
  • Loss of muscle control
  • Cataplexy-usually with narcolepsy
  • Psychogenic

12
The Initial Evaluation
  • Careful History - from patient and witnesses
    this is the most important tool in the diagnosis!
  • Prior to attack, onset, eyewitnesses, end of the
    attack, PMH, FH, drug history?
  • Physical exam- include orthostatic BP
  • Standard EKG

13
Evaluation
  • The use of EEG, CT, MRI , carotid dopplers are
    not usually helpful in the workup of syncope
  • Hospitalize patients when the features suggest a
    cardiac cause, when it results in severe injury,
    or when the syncope is frequent

14
Evaluation
  • When the cause of the syncope is not evident
    after the initial evaluation and there is
    evidence of heart disease then the possibility of
    cardiac syncope must be entertained as these
    patients have a high mortality at one year(18-30
    mortality)
  • Cardiac evaluation echo, stress test,
    holter/loop and EP testing.
  • In a patient with cardiac disease but with
    negative cardiac workup, then proceed with tilt
    testing and / or implantable loop recorder.

15
Evaluation
  • In those without heart disease, then tilt table
    testing and carotid massage (more important in
    the patients gt 40) for neurally mediated syncope
    is recommended for those with recurrent or severe
    syncope.
  • SAECG has fallen out of favor. If it is normal it
    helps.

16
Test/Procedure Yield (based on mean time to diagnosis of 5.1 months7
History and Physical (including carotid sinus massage) 49-85 1, 2
ECG 2-11 2
Electrophysiology Study without SHD 11 3
Electrophysiology Study with SHD 49 3
Tilt Table Test (without SHD) 11-87 4, 5
Ambulatory ECG Monitors
Holter 2 7
External Loop Recorder (2-3 weeks duration) 20 7
Insertable Loop Recorder (up to 14 months duration) 65-88 6, 7
Neurological (Head CT Scan, Carotid Doppler) 0-4 4,5,8,9,10
17
Reveal Plus ILR
  • Offers up to 14 months of continuous, leadless
    ECG monitoring
  • High diagnostic yield (65-88)
  • High patient compliance
  • Patient and auto triggered to capture ECG

Patient Activator
Reveal Plus ILR
9790 Programmer
18
  • Implant zone for optimal auto activation
    performance
  • Implant parallel to the midline in the region
  • From left parasternal area to the mid-clavicular
    line
  • First to the fourth rib

Implanting in this zone helps minimize
inappropriate auto activation motion artifact
due to body/arm movement and changes in posture
19
Johns Hopkins Hospital, Baltimore, Maryland
20
Randomized Assessment of Syncope Trial
(RAST) Comparison of the Implantable Loop
Recorder with Conventional Diagnostic Testing for
Unexplained Syncope1
Andrew D. Krahn, George J. Klein, Raymond Yee,
Allan C. Skanes University of Western
Ontario London Ontario Canada
1. Krahn A, et al. Circ. 2001104(11)46-51
21
Methods
  • Prospective randomized trial (60 patients with
    unexplained syncope referred for cardiac
    investigation)
  • Inclusion
  • Recurrent unexplained syncope
  • Referred to the arrhythmia service for cardiac
    investigation
  • No clinical diagnosis after history, physical,
    ECG and at least 24 hours of cardiac monitoring
  • Exclusion
  • LVEF lt 35
  • Unable to give informed consent
  • Major morbidity precluding 1 year of follow-up

22
Methods
  • Conventional Investigations
  • ELR then HUT then EPS(see below for definitions)
  • ILR4
  • Left sided implant with antibiotics
  • Patient education
  • 1 year of follow-up
  • Crossover
  • After primary arm was completed, patients were
    offered crossover to facilitate diagnosis
  1. External loop recorder
  2. Head up tilt test
  3. Electrophysiological study
  4. Reveal Insertable Loop Recorder, Model 9525

23
Results
ILR (n30) Conventional (n30) Age
(years) 64 /- 14 68 /- 14 Gender (
male) 19 (63) 14 (47) Syncopal Episodes 4.1
/- 3.3 5.8 /- 6.6 Duration of Syncope
(yrs) 6.6 /- 12 8.7 /- 2.7 LVEF () 55 /-
8 55 /- 6
24
RAST Results
25
RAST Crossover Results
26
RAST Results
Diagnosis By ILR Conventional p
value Primary Strategy 14/27 (52) 6/30
(20) p0.012 Crossover 8/13 (62) 1/6
(17) p0.069 Primary and Crossover 22/40
(55) 7/36 (19) p0.0014 3 primary ILRs and 8
crossover ILRs have not completed follow up.
27
Conclusions
  • This prospective randomized trial suggests that
    the implanted loop recorder has a superior
    diagnostic yield as a primary strategy.
  • The diagnostic yield of conventional testing in
    these patients is disappointing (19).
  • The loop recorder retains high utility when used
    after conventional testing is negative.
  • Consideration should be given to use at an
    earlier stage in the diagnostic cascade in this
    patient population.

28
Asystole Brady NormalSR Tachy Syncope Recurrence
Pilot studyCirculation, 95 N/A 7 (47) 6 (40) 2 (13) 15/1694
Krahn et alCirculation, 99 N/A 14 (69) 7 (30) 2 (9) 23/8527
Nierop et alPACE, 2000 N/A 4 (29) 6 (43) 4 (29) 14/3540
ISSUE studyCirculation, 2001 16 (50) 3 (9) 12 (34) 1 (3) 32/11129
Total 4452 4452 3137 911 84/24734
29
Indications
The Reveal Plus Insertable Loop Recorder is
indicated for
  • Patients with clinical syndromes or situations at
    increased risk of cardiac arrhythmias
  • Patients who experience transient symptoms that
    may suggest a cardiac arrhythmia

30
Tilt Table Diagnosis
  • Neurocardiogenic-seen in 50 of patients with
    heart disease and 75 of patients without heart
    disease who present with syncope
  • Type 1 mixed bp falls before heart rate and the
    heart rate does not get lt40 and no pauses gt3 secs
    and heart rate falls at the time of syncope
  • Type 2a cardioinhibitory without asystole-bp
    falls before the heart rate and heart rate gets
    below 40 but no asystole gt 3 secs
  • Type 2b cardioinhibitory with asystole-heart
    rate falls below 40 for gt 10secs and asystole is
    present gt3 secs
  • Type 3 pure vasodepressor-bp falls but heart
    rate does not fall gt10 from peak heart rate .

31
Tilt Table Diagnosis
  • Dysautonomic
  • Gradual decline in the systolic and diastolic bp
    with or without a drop in the heart rate.
  • Orthostatic intolerance is the key problem
  • POTS-Postural orthostatic tachycardia syndrome
  • An excessive heart rate response to maintain a
    low normal blood pressure. Will have an excess of
    gt30 beats increase when placed upright

32
Tilt Table Diagnosis
  • Cerebral syncope
  • Associated with cerebral vasoconstriction in the
    absence of systemic hypotension and would need a
    transcranial Doppler for confirmation

33
Protocols
  • Westminster
  • Passive tilt for 45 minutes at 60-80 degrees and
    has a positive rate of 75 with specificity of
    95

34
Protocols
  • Italian
  • Passive tilt for 20 minutes and the challenge
    with SUBLINGUAL NITROGLYCERIN while still upright
    and has specificity of 94.
  • Will see a progressive drop in the BP with no
    bradycardia if the effect is due to the drug
    alone and this is not a positive test..seen in
    20!

35
Syncope
History and Physical ECG
KnownSHD
NoSHD
gt 30 days gt 2 Events
lt 30 days
Echo
EPS
-

Treat
Tilt/ILR
About PowerShow.com